Aquestive Therapeutics (AQST) Competitors $3.95 +0.12 (+3.13%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$4.14 +0.19 (+4.94%) As of 08:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AQST vs. EWTX, SDGR, AVDL, ARDX, JANX, HROW, VERA, AMPH, SNDX, and ETNBShould you be buying Aquestive Therapeutics stock or one of its competitors? The main competitors of Aquestive Therapeutics include Edgewise Therapeutics (EWTX), Schrodinger (SDGR), Avadel Pharmaceuticals (AVDL), Ardelyx (ARDX), Janux Therapeutics (JANX), Harrow (HROW), Vera Therapeutics (VERA), Amphastar Pharmaceuticals (AMPH), Syndax Pharmaceuticals (SNDX), and 89BIO (ETNB). These companies are all part of the "pharmaceutical products" industry. Aquestive Therapeutics vs. Its Competitors Edgewise Therapeutics Schrodinger Avadel Pharmaceuticals Ardelyx Janux Therapeutics Harrow Vera Therapeutics Amphastar Pharmaceuticals Syndax Pharmaceuticals 89BIO Edgewise Therapeutics (NASDAQ:EWTX) and Aquestive Therapeutics (NASDAQ:AQST) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Which has preferable earnings and valuation, EWTX or AQST? Aquestive Therapeutics has higher revenue and earnings than Edgewise Therapeutics. Edgewise Therapeutics is trading at a lower price-to-earnings ratio than Aquestive Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdgewise TherapeuticsN/AN/A-$133.81M-$1.55-9.45Aquestive Therapeutics$57.56M6.84-$44.14M-$0.70-5.64 Is EWTX or AQST more profitable? Edgewise Therapeutics has a net margin of 0.00% compared to Aquestive Therapeutics' net margin of -147.38%. Aquestive Therapeutics' return on equity of 0.00% beat Edgewise Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Edgewise TherapeuticsN/A -30.65% -29.18% Aquestive Therapeutics -147.38%N/A -63.87% Do analysts recommend EWTX or AQST? Edgewise Therapeutics presently has a consensus target price of $40.55, indicating a potential upside of 176.95%. Aquestive Therapeutics has a consensus target price of $10.14, indicating a potential upside of 156.78%. Given Edgewise Therapeutics' higher possible upside, equities research analysts clearly believe Edgewise Therapeutics is more favorable than Aquestive Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edgewise Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.91Aquestive Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk and volatility, EWTX or AQST? Edgewise Therapeutics has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500. Comparatively, Aquestive Therapeutics has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Do institutionals & insiders believe in EWTX or AQST? 32.5% of Aquestive Therapeutics shares are held by institutional investors. 23.2% of Edgewise Therapeutics shares are held by company insiders. Comparatively, 7.9% of Aquestive Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor EWTX or AQST? In the previous week, Edgewise Therapeutics had 7 more articles in the media than Aquestive Therapeutics. MarketBeat recorded 11 mentions for Edgewise Therapeutics and 4 mentions for Aquestive Therapeutics. Edgewise Therapeutics' average media sentiment score of 1.08 beat Aquestive Therapeutics' score of 0.34 indicating that Edgewise Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edgewise Therapeutics 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aquestive Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAquestive Therapeutics beats Edgewise Therapeutics on 8 of the 15 factors compared between the two stocks. Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AQST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AQST vs. The Competition Export to ExcelMetricAquestive TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$375.96M$2.50B$5.77B$9.73BDividend YieldN/A48.51%6.66%4.49%P/E Ratio-5.6422.6482.4326.60Price / Sales6.84543.48504.73158.83Price / CashN/A26.3325.7028.92Price / Book-5.416.7910.936.56Net Income-$44.14M$32.94M$3.28B$266.04M7 Day Performance3.13%0.80%0.10%-0.89%1 Month Performance-1.74%6.13%8.93%4.34%1 Year Performance-6.84%-0.23%51.89%24.06% Aquestive Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AQSTAquestive Therapeutics1.7097 of 5 stars$3.95+3.1%$10.14+156.8%-5.7%$375.96M$57.56M-5.64160Analyst UpgradeEWTXEdgewise Therapeutics2.0459 of 5 stars$14.30-3.7%$40.55+183.5%-18.1%$1.56BN/A-9.2360SDGRSchrodinger2.878 of 5 stars$19.54-3.8%$27.83+42.4%-6.1%$1.50B$207.54M-7.88790AVDLAvadel Pharmaceuticals3.6977 of 5 stars$14.81-2.8%$19.67+32.8%-2.1%$1.48B$169.12M-493.6770Trending NewsAnalyst ForecastAnalyst RevisionARDXArdelyx4.4827 of 5 stars$6.06-0.8%$11.50+89.8%+15.6%$1.47B$333.61M-26.3590News CoveragePositive NewsAnalyst UpgradeJANXJanux Therapeutics3.1256 of 5 stars$23.01-5.3%$86.90+277.7%-48.8%$1.46B$10.59M-12.7830News CoverageAnalyst ForecastHROWHarrow3.5503 of 5 stars$37.36-4.5%$64.67+73.1%-5.8%$1.45B$199.61M0.00180VERAVera Therapeutics2.8774 of 5 stars$21.34-5.4%$63.00+195.2%-40.1%$1.44BN/A-5.9640News CoveragePositive NewsAMPHAmphastar Pharmaceuticals3.4124 of 5 stars$29.83-2.2%$31.50+5.6%-37.4%$1.42B$731.97M11.172,028Positive NewsSNDXSyndax Pharmaceuticals4.4263 of 5 stars$15.66-3.6%$38.00+142.7%-21.5%$1.40B$23.68M-4.03110News CoveragePositive NewsETNB89BIO2.5994 of 5 stars$9.10-3.5%$26.63+192.6%+5.2%$1.40BN/A0.0040News CoveragePositive News Related Companies and Tools Related Companies EWTX Alternatives SDGR Alternatives AVDL Alternatives ARDX Alternatives JANX Alternatives HROW Alternatives VERA Alternatives AMPH Alternatives SNDX Alternatives ETNB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AQST) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AQST Stock Alerts